Akums Drugs IPO set for strong debut with expected 10-15% gains
Akums Drugs and Pharmaceuticals' IPO is expected to debut with a 10-15% gain on August 6, driven by strong subscription numbers.
Stay updated with the latest news and articles about Akums Drugs IPO.
Akums Drugs and Pharmaceuticals' IPO is expected to debut with a 10-15% gain on August 6, driven by strong subscription numbers.